Scholars Central

Editorial Board Member

Andrew Hague , BA (Hons), Dip M

Professor, Professor, Advanced Medicine, United Kingdom

About

As published by the journal they serve.

Andrew Hague’s interest in the technology that was to become CellSonic began in 1987 with the first lithotripter in Britain. Using his own capital, he developed the CellSonic VIPP machines and sold them around the world. In 2016, Professor Hague devised the protocol for curing cancer and this is now used in CellSonic Clinics in India, Peru, Spain and Poland. Many more are planned. There are no side effects, drugs must not be used and the cancer is stopped immediately. CellSonic VIPP has been used for physiotherapy and sports medicine for twenty years. Where the patient also had cut skin the cure for non-healing wounds was discovered and that led to repairing nerves and pain release. Professor Hague is the owner of CellSonic Limited.

Research interests

  • Tissue regeneration
  • Cancer - diagnosis and treatment
  • Diabetes - reversal
  • Alzheimer’s disease
  • Parkinson’s disease
  • Genomic analysis

Journals they serve

The seats these journals name them in.

Articles we hold

Articles in the journals they serve whose byline carries this name.

No article in our collection carries this name on its byline. Not every article names its authors in a way that can be matched, so this is not a list of everything they have written.

This page holds what the journals publish about this profile: no contact details, and nothing gathered from anywhere else. Ask us to correct or remove this profile.

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels